Skip to content

Clinical trials

Neuralgia, Postherpetic trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuralgia, Postherpetic Country / region: Germany Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20043
20061
20082
20091
20102
20113
20123
20131
20141
20171
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
Allergan2
Ruhr University of Bochum2
UCB Pharma2
Astellas Pharma Europe B.V.1
Astellas Pharma Europe Ltd.1
Bial - Portela C S.A.1
Charite University, Berlin, Germany1
Dominik Irnich1
Merz Therapeutics GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuralgia, Postherpetic20
Neuralgia7
Peripheral Nerve Injuries4
Herpes Zoster2
Pain2
Causalgia1
Chronic Pain1
Cluster Headache1
Diabetic Neuropathies1
Peripheral Nervous System Diseases1

Trials

Showing 51 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.